Gastric cancer

被引:102
作者
Catalano, V [1 ]
Labianca, R
Beretta, GD
Gatta, G
de Braud, F
Van Cutsem, E
机构
[1] Azienda Osped Osped San Salvatore, Pesaro, Italy
[2] Osped Riuniti Bergamo, I-24100 Bergamo, Italy
[3] Ist Nazl Studio & Cura Tumori, Milan, Italy
[4] START Project, Milan, Italy
[5] Ist Europeo Oncol, Milan, Italy
[6] Univ Hosp Gasthuisberg, B-3000 Louvain, Belgium
关键词
D O I
10.1016/j.critrevonc.2005.01.002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Gastric cancer is one of the most common cancers and one of the most frequent causes of cancer-related deaths. The incidence, diagnostic studies, and therapeutic options have undergone important changes in the last decades, but the prognosis for gastric cancer patients remains poor, especially in more advanced stages. Surgery is the mainstay of treatment of this disease, even if it is associated with a high rate of locoregional and distant recurrence. There is ongoing debate regarding the role of adjuvant treatment In advanced disease, palliation of symptoms, rather than cure, is the primary goal of patient management. Several combination therapies have been developed and have been examined in phase III trials; however, in most cases, they have failed to demonstrate a survival advantage over the reference arm. This review summarizes the most important recommendations for the management of patients with gastric cancer. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:209 / 241
页数:33
相关论文
共 386 条
[1]   DNA aneuploidy by flow cytometry is an independent prognostic factor in gastric cancer [J].
Abad, M ;
Ciudad, J ;
Rincon, MR ;
Silva, I ;
Paz-Bouza, JI ;
Lopez, A ;
Alonso, AG ;
Bullon, A ;
Orfao, A .
ANALYTICAL CELLULAR PATHOLOGY, 1998, 16 (04) :223-231
[2]  
ADACHI Y, 1990, ARCH PATHOL LAB MED, V114, P1046
[3]  
Adachi Y, 1997, AM J GASTROENTEROL, V92, P872
[4]   Enhanced staging and all chemotherapy preoperatively in patients with potentially resectable gastric carcinoma [J].
Ajani, JA ;
Mansfield, PF ;
Lynch, PM ;
Pisters, PW ;
Feig, B ;
Dumas, P ;
Evans, DB ;
Raijman, I ;
Hargraves, K ;
Curley, S ;
Ota, DM .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (08) :2403-2411
[5]  
Ajani JA, 2002, ONCOLOGY-NY, V16, P16
[6]  
AJANI JA, 1991, CANCER-AM CANCER SOC, V68, P1501, DOI 10.1002/1097-0142(19911001)68:7<1501::AID-CNCR2820680706>3.0.CO
[7]  
2-L
[8]   PREOPERATIVE AND POSTOPERATIVE COMBINATION CHEMOTHERAPY FOR POTENTIALLY RESECTABLE GASTRIC-CARCINOMA [J].
AJANI, JA ;
MAYER, RJ ;
OTA, DM ;
STEELE, GD ;
EVANS, D ;
ROH, M ;
SUGARBAKER, DJ ;
DUMAS, P ;
GRAY, C ;
VENA, DA ;
STABLEIN, DM .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (22) :1839-1844
[9]  
AJANI JA, 2003, P AN M AM SOC CLIN, V22, pA249
[10]   IMPROVING SURVIVAL IN GASTRIC-CANCER - REVIEW OF 5-YEAR SURVIVAL RATES IN ENGLISH-LANGUAGE PUBLICATIONS FROM 1970 [J].
AKOH, JA ;
MACINTYRE, IMC .
BRITISH JOURNAL OF SURGERY, 1992, 79 (04) :293-299